(Date:11/30/2009)...ATTLE, Nov. 30 Cell Ther...ced today that its new class of platinum-based ant...ated a stronger anti-tumor potency and activity co...unds as well as the ability to overcome cisplatin-... presented in a paper titled "Novel Bis-platinum C...
(Date:11/30/2009)... SHANGHAI, Nov. 30 /PRNewswire-Asia/ -- WuXi Pharm...technology, and medical-device research and,develo... and the United States,announced that it had been...,2009 list for the fifth consecutive year. The lis...hina,s technology, media, and telecommunications,i...
(Date:11/30/2009)... , AMSTERDAM, November 30 /PRNew...publisher of scientific, medical and technical pro...nch of Embase, its comprehensive biomedical,databa...m more than 7,000,active, peer reviewed journals. ...e advancement of new biomedical,and pharmaceutical...
(Date:11/28/2009)... The Vanuatu National Advisory Committee on C...Communication (SNC) Project in collaboration with ...s Ltd. of New Zealand have generated preliminary c... form the background for the country’s SNC r...n on Climate Change (UNFCCC). , ...
Breaking Biology Technology:New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 3WuXi PharmaTech Named in Deloitte Technology Fast 50 China 2009 List for the Fifth Consecutive Year 2Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 2Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 3Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 2Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 3Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 4..., Dec. 20 Conatus Pharmaceuticals Inc. today,anno...vel drug candidate,for the treatment of liver dise...ion in patients who have failed the approved stand... drug candidate, CTS-1027, is being studied as,a t...resulting from,infection by HCV. CTS-1027 inhibits...
... Calif., Dec. 20 Ardea Biosciences,Inc. (Nasdaq: ...velopment of,small-molecule therapeutics for the t...y diseases, today announced that it has entered in...stitutional investors to raise,approximately $40 m... 3.0,million newly issued shares of its common sto...
..., Dec. 20 /Xinhua-PRNewswire-FirstCall/ -- China T...TDC, "the Company" or "CTDC"), a,provider of clean...ing on,solar energy business in China, today annou...ategic plan to focus the Company,s management and,...olar energy., On December 18, 2007, the Company d...
Other Biology Technology:Conatus Pharmaceuticals Initiates a Phase 2 Clinical Trial for the Treatment of Hepatitis 2Ardea Biosciences Announces $40 Million Private Placement 2Ardea Biosciences Announces $40 Million Private Placement 3CTDC Announces the Disposal of Non-core Business 2...k, Super-Small! Capture high-resolution chemilumi...c-It Imaging System. High-sensitivity camera is co...und noise and wide dynamic range for high quality ...abinet provides optimum conditions for chemilumine...
Goat Anti-Microbial Sarcosine Oxidase Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-Human ODZ1 Polyclonal Antibody, Unconjugated from Atlas Antibodies
Chicken Anti-HADHSC Azide Free Polyclonal Antibody, Unconjugated from Abcam
Biology Products: